Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2)

[Edit]

ALI1; DEGA; Alivin-1; Amphoterin-Induced Gene And Open Reading Frame 2; Differentially expressed in gastric adenocarcinomas

Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2)
DEGA, a novel cDNA differentially expressed in human gastric adenocarcinomas. The DEGA gene product contains a signal peptide, five leucine-rich repeat motifs and a single IgG, and transmembrane domain, suggesting its residence on the plasma membrane. Transfection of 293 cells with a DEGA-GFP fusion construct confirmed its cell surface localization. Although the cytosolic portion of the DEGA gene product does not contain known protein domains, approximately one-fifth of these residues are either a serine or a threonine, suggesting that DEGA may play a role in signal transduction. BLAST searches revealed DEGA to be an exact match to AMIGO-2, a recently identified, but functionally uncharacterized protein related to AMIGO, a leucine-rich repeat containing cell adhesion molecule implicated in axon tract development.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Adhesion Molecule With Ig Like Domain Protein 2 (AMIGO2) ELISA Kit Customized Service Offer
  1. "AMIGO, a transmembrane protein implicated in axon tract development, defines a novel protein family with leucine-rich repeats."J. Cell Biol. 160:963-973(2003) [PubMed] [Europe PMC] [Abstract].
  2. "DEGA/AMIGO-2, a leucine-rich repeat family member, differentially expressed in human gastric adenocarcinoma: effects on ploidy, chromosomal stability, cell adhesion/migration and tumorigenicity."Oncogene 23:5056-5067(2004) [PubMed] [Europe PMC] [Abstract]
  3. "The full-ORF clone resource of the German cDNA consortium."BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract]
  4. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] and Uterus.
  5. "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks."Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract]